@import url(http://finance.paidcontent.org/client/paidcontent/privatelabel.css);
February 18, 2012 at 08:49 AM EST
The Week in Review: ChinaBio® Partnering Forum 2012 Scheduled for Suzhou
ChinaBio® and EBD Group announced the fourth annual ChinaBio® Partnering Forum, the premier partnering event for China pharma, will be held in Suzhou on May 23-24, 2012; Beijing Leadman Biochemistry raised $79 million in an IPO on the Shenzhen’s ChiNext exchange; Zhejiang Medicine offered 70 million shares in a private placement that will add $254 million to the company’s treasury; BioDuro signed a three-year agreement with Dow AgroSciences to develop crop protection molecules; BGI launched its first European Genome Research Center in Copenhagen; China plans to expand its list of essential drugs to 800, up from 307 in the initial group released in 2009; GlaxoSmithKline will begin investigating traditional Chinese medicines as a source for patentable drugs; Asymchem Laboratories opened a new large-scale manufacturing plant in Dunhua, China; and Tianyin Pharma began construction of a new manufacturing facility in Qionglai. More details…. Stock Symbols: (SHE: 300289) (SHA: 600216) (NYSE: GSK) (AMEX: TPI) Share this with colleagues: var switchTo5x=true; stLight.options({publisher:'d7871f5b-67bc-4d30-b66f-1465d0b97213'});  
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here